Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China’s latest cost squeeze
December 4, 2021
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China’s latest cost squeeze
aliu
Mon, 11/29/2021 – 10:27
Read the source article at Pharma News
2021-11-29 16:26:34